EE257 Budget Consequences of Five Benign Prostatic Hyperplasia Treatment Options - US Medicare Perspective
| Autor: | Chughtai, B, Rojanasarot, S, Neeser, K, Gultyaev, D, Herscu, P, Fu, S, Bhattacharyya, SK, El-Arabi, A, Cutone, B, McVary, KT |
|---|---|
| Zdroj: | In Value in Health July 2022 25(7) Supplement:S384-S384 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect